EMERGENT BIOSOLUTIONS INC. Cost of Goods Sold (Deprecated 2018-01-31)
EMERGENT BIOSOLUTIONS INC. (EBS) reported Cost of Goods Sold (Deprecated 2018-01-31) of $58.04 million for the 3-month period ending 2018-03-31, per its 10-Q filed 2018-05-04.
Discontinued › Expense Statement
us-gaap:CostOfGoodsSold · last filed 2018-05-04
- EMERGENT BIOSOLUTIONS INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2018-03-31 was $58.04M, a 25.31% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-12-31 was $70.26M, a 83.64% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-09-30 was $44.50M, a 12.49% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. cost of goods sold (deprecated 2018-01-31) for the quarter ending 2017-06-30 was $34.62M, a 17.51% increase year-over-year.
- EMERGENT BIOSOLUTIONS INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2017 was $195.71M, a 49.07% increase from fiscal 2016.
- EMERGENT BIOSOLUTIONS INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2016 was $131.28M, a 22.14% increase from fiscal 2015.
- EMERGENT BIOSOLUTIONS INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2015 was $107.49M, a 5.42% increase from fiscal 2014.
- EMERGENT BIOSOLUTIONS INC. cost of goods sold (deprecated 2018-01-31) for fiscal 2014 was $101.96M, a 64.12% increase from fiscal 2013.
| Period end | Cost of Goods Sold (Deprecated 2018-01-31) 3 month | Cost of Goods Sold (Deprecated 2018-01-31) 3 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 6 month | Cost of Goods Sold (Deprecated 2018-01-31) 6 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 9 month | Cost of Goods Sold (Deprecated 2018-01-31) 9 month as first filed | Cost of Goods Sold (Deprecated 2018-01-31) 12 month | Cost of Goods Sold (Deprecated 2018-01-31) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2018-03-31 | $58.04M 10-Q · filed 2018-05-04 | $128.30M derived: sum of 2 quarters · filed 2018-05-04 | $172.81M derived: sum of 3 quarters · filed 2018-05-04 | $207.43M derived: sum of 4 quarters · filed 2018-05-04 | ||||
| 2017-12-31 | $70.26M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $114.76M derived: sum of 2 quarters · filed 2018-02-23 | $149.38M derived: sum of 3 quarters · filed 2018-02-23 | $195.71M 10-K · filed 2018-02-23 | ||||
| 2017-09-30 | $44.50M 10-Q · filed 2017-11-03 | $79.13M derived: sum of 2 quarters · filed 2017-11-03 | $125.45M 10-Q · filed 2017-11-03 | $163.71M derived: sum of 4 quarters · filed 2018-05-04 | ||||
| 2017-06-30 | $34.62M 10-Q · filed 2017-08-04 | $80.95M 10-Q · filed 2017-08-04 | $119.20M derived: sum of 3 quarters · filed 2018-05-04 | $158.76M derived: sum of 4 quarters · filed 2018-05-04 | ||||
| 2017-03-31 | $46.32M 10-Q · filed 2018-05-04 | $84.58M derived: sum of 2 quarters · filed 2018-05-04 | $124.14M derived: sum of 3 quarters · filed 2018-05-04 | $153.61M derived: sum of 4 quarters · filed 2018-05-04 | ||||
| 2016-12-31 | $38.26M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $77.82M derived: sum of 2 quarters · filed 2018-02-23 | $107.28M derived: sum of 3 quarters · filed 2018-02-23 | $131.28M 10-K · filed 2018-02-23 | ||||
| 2016-09-30 | $39.56M 10-Q · filed 2017-11-03 | $69.03M derived: sum of 2 quarters · filed 2017-11-03 | $93.03M 10-Q · filed 2017-11-03 | $127.43M derived: sum of 4 quarters · filed 2018-02-23 | ||||
| 2016-06-30 | $29.46M 10-Q · filed 2017-08-04 | $35.61M 10-Q · filed 2016-08-05 | $53.47M 10-Q · filed 2017-08-04 | $64.11M 10-Q · filed 2016-08-05 | $87.87M derived: sum of 3 quarters · filed 2018-02-23 | $123.11M derived: sum of 4 quarters · filed 2018-02-23 | ||
| 2016-03-31 | $24.00M 10-Q · filed 2017-05-05 | $28.50M 10-Q · filed 2016-05-06 | $58.40M derived: sum of 2 quarters · filed 2018-02-23 | $93.64M derived: sum of 3 quarters · filed 2018-02-23 | $120.91M derived: sum of 4 quarters · filed 2018-02-23 | |||
| 2015-12-31 | $34.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $69.64M derived: sum of 2 quarters · filed 2018-02-23 | $96.91M derived: sum of 3 quarters · filed 2018-02-23 | $107.49M 10-K · filed 2018-02-23 | $124.30M 10-K · filed 2016-02-29 | |||
| 2015-09-30 | $35.24M 10-Q · filed 2016-11-09 | $38.51M 10-Q · filed 2015-11-06 | $62.51M derived: sum of 2 quarters · filed 2016-11-09 | $73.08M 10-Q · filed 2016-11-09 | $84.53M 10-Q · filed 2015-11-06 | $97.29M derived: sum of 4 quarters · filed 2017-02-28 | ||
| 2015-06-30 | $27.27M 10-Q · filed 2016-08-05 | $46.01M 10-Q · filed 2016-08-05 | $62.05M derived: sum of 3 quarters · filed 2017-02-28 | $94.47M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2015-03-31 | $18.75M 10-Q · filed 2016-05-06 | $34.78M derived: sum of 2 quarters · filed 2017-02-28 | $67.21M derived: sum of 3 quarters · filed 2017-02-28 | $101.71M derived: sum of 4 quarters · filed 2017-02-28 | ||||
| 2014-12-31 | $16.04M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $48.46M derived: sum of 2 quarters · filed 2017-02-28 | $82.97M derived: sum of 3 quarters · filed 2017-02-28 | $101.96M 10-K · filed 2017-02-28 | $118.41M 10-K · filed 2015-03-09 | |||
| 2014-09-30 | $32.42M 10-Q · filed 2015-11-06 | $66.93M derived: sum of 2 quarters · filed 2015-11-06 | $85.93M 10-Q · filed 2015-11-06 | $105.35M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-06-30 | $34.51M 10-Q · filed 2015-08-06 | $53.50M 10-Q · filed 2015-08-06 | $72.92M derived: sum of 3 quarters · filed 2016-02-29 | $92.99M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2014-03-31 | $19.00M 10-Q · filed 2015-05-08 | $38.42M derived: sum of 2 quarters · filed 2016-02-29 | $58.48M derived: sum of 3 quarters · filed 2016-02-29 | $75.43M derived: sum of 4 quarters · filed 2016-02-29 | ||||
| 2013-12-31 | $19.42M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $39.48M derived: sum of 2 quarters · filed 2016-02-29 | $56.43M derived: sum of 3 quarters · filed 2016-02-29 | $62.13M 10-K · filed 2016-02-29 | ||||
| 2013-09-30 | $20.06M 10-Q · filed 2014-11-10 | $37.01M derived: sum of 2 quarters · filed 2014-11-10 | $42.71M 10-Q · filed 2014-11-10 | $57.86M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-06-30 | $16.95M 10-Q · filed 2014-08-08 | $22.64M 10-Q · filed 2014-08-08 | $37.79M derived: sum of 3 quarters · filed 2015-03-09 | $48.02M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2013-03-31 | $5.70M 10-Q · filed 2014-05-12 | $20.85M derived: sum of 2 quarters · filed 2015-03-09 | $31.08M derived: sum of 3 quarters · filed 2015-03-09 | $44.26M derived: sum of 4 quarters · filed 2015-03-09 | ||||
| 2012-12-31 | $15.15M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $25.38M derived: sum of 2 quarters · filed 2015-03-09 | $38.57M derived: sum of 3 quarters · filed 2015-03-09 | $46.08M 10-K · filed 2015-03-09 | ||||
| 2012-09-30 | $10.23M 10-Q · filed 2013-11-08 | $23.42M derived: sum of 2 quarters · filed 2013-11-08 | $30.93M 10-Q · filed 2013-11-08 | $45.26M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-06-30 | $13.19M 10-Q · filed 2013-08-06 | $20.70M 10-Q · filed 2013-08-06 | $35.02M derived: sum of 3 quarters · filed 2014-03-10 | $45.73M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2012-03-31 | $7.51M 10-Q · filed 2013-05-03 | $21.84M derived: sum of 2 quarters · filed 2014-03-10 | $32.55M derived: sum of 3 quarters · filed 2014-03-10 | $48.61M derived: sum of 4 quarters · filed 2014-03-10 | ||||
| 2011-12-31 | $14.33M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-10 | $25.03M derived: sum of 2 quarters · filed 2014-03-10 | $41.10M derived: sum of 3 quarters · filed 2014-03-10 | $42.17M 10-K · filed 2014-03-10 | ||||
| 2011-09-30 | $10.71M 10-Q · filed 2012-11-01 | $26.77M derived: sum of 2 quarters · filed 2012-11-01 | $27.84M 10-Q · filed 2012-11-01 | $44.84M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2011-06-30 | $16.07M 10-Q · filed 2012-08-03 | $17.14M 10-Q · filed 2012-08-03 | $34.13M derived: sum of 3 quarters · filed 2013-03-08 | $45.67M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2011-03-31 | $1.07M 10-Q · filed 2012-05-04 | $18.07M derived: sum of 2 quarters · filed 2013-03-08 | $29.60M derived: sum of 3 quarters · filed 2013-03-08 | $40.67M derived: sum of 4 quarters · filed 2013-03-08 | ||||
| 2010-12-31 | $17.00M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $28.53M derived: sum of 2 quarters · filed 2013-03-08 | $39.61M derived: sum of 3 quarters · filed 2013-03-08 | $47.11M 10-K · filed 2013-03-08 | ||||
| 2010-09-30 | $11.53M 10-Q · filed 2011-11-04 | $22.61M derived: sum of 2 quarters · filed 2011-11-04 | $30.12M 10-Q · filed 2011-11-04 | |||||
| 2010-06-30 | $11.08M 10-Q · filed 2011-08-05 | $18.58M 10-Q · filed 2011-08-05 | ||||||
| 2009-12-31 | $46.26M 10-K · filed 2012-03-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ENANTA PHARMACEUTICALS INC (ENTA) | United States | $0.349B | -6.72 |
| Larimar Therapeutics, Inc. (LRMR) | United States | $0.344B | -1.83 |
| Vogenx, Inc. (VOGX) | United States | $0.355B | |
| Benitec Biopharma Inc. (BNTC) | United States | $0.337B | -10.08 |
| BioAge Labs, Inc. (BIOA) | United States | $0.333B | -11.88 |
| BridgeBio Oncology Therapeutics, Inc. (BBOT) | United States | $0.320B | -3.35 |
| Evommune, Inc. (EVMN) | United States | $0.320B | -5.10 |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |